Compile Data Set for Download or QSAR
Report error Found 105 Enz. Inhib. hit(s) with all data for entry = 12882
TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737208(US20250136592, Example 41)
Affinity DataIC50: 14nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737245(US20250136592, Example 78)
Affinity DataIC50: 14nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737246(US20250136592, Example 79)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737168(US20250136592, Example 1)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737222(US20250136592, Example 55)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737232(US20250136592, Example 65)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737247(US20250136592, Example 80)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737196(US20250136592, Example 29)
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737219(US20250136592, Example 52)
Affinity DataIC50: 25nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737216(US20250136592, Example 49)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737214(US20250136592, Example 47)
Affinity DataIC50: 28nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737233(US20250136592, Example 66)
Affinity DataIC50: 29nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737215(US20250136592, Example 48)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737251(US20250136592, Example 84)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737207(US20250136592, Example 40)
Affinity DataIC50: 34nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737235(US20250136592, Example 68)
Affinity DataIC50: 35nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737210(US20250136592, Example 43)
Affinity DataIC50: 37nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737220(US20250136592, Example 53)
Affinity DataIC50: 38nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737253(US20250136592, Example 86)
Affinity DataIC50: 41nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737200(US20250136592, Example 33)
Affinity DataIC50: 42nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737203(US20250136592, Example 36)
Affinity DataIC50: 43nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737206(US20250136592, Example 39)
Affinity DataIC50: 43nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737254(US20250136592, Example 87)
Affinity DataIC50: 47nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737255(US20250136592, Example 88)
Affinity DataIC50: 47nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737201(US20250136592, Example 34)
Affinity DataIC50: 48nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737197(US20250136592, Example 30)
Affinity DataIC50: 51nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737248(US20250136592, Example 81)
Affinity DataIC50: 51nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737257(US20250136592, Example 90)
Affinity DataIC50: 51nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737182(US20250136592, Example 15)
Affinity DataIC50: 53nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737226(US20250136592, Example 59)
Affinity DataIC50: 53nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737204(US20250136592, Example 37)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737238(US20250136592, Example 71)
Affinity DataIC50: 56nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737252(US20250136592, Example 85)
Affinity DataIC50: 56nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737266(US20250136592, Example 99)
Affinity DataIC50: 56nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737198(US20250136592, Example 31)
Affinity DataIC50: 57nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737199(US20250136592, Example 32)
Affinity DataIC50: 58nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737265(US20250136592, Example 98)
Affinity DataIC50: 58nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737213(US20250136592, Example 46)
Affinity DataIC50: 61nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737250(US20250136592, Example 83)
Affinity DataIC50: 64nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737234(US20250136592, Example 67)
Affinity DataIC50: 75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737260(US20250136592, Example 93)
Affinity DataIC50: 76nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737264(US20250136592, Example 97)
Affinity DataIC50: 76nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737179(US20250136592, Example 12)
Affinity DataIC50: 78nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737240(US20250136592, Example 73)
Affinity DataIC50: 78nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737241(US20250136592, Example 74)
Affinity DataIC50: 79nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737209(US20250136592, Example 42)
Affinity DataIC50: 84nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737183(US20250136592, Example 16)
Affinity DataIC50: 88nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737228(US20250136592, Example 61)
Affinity DataIC50: 90nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737231(US20250136592, Example 64)
Affinity DataIC50: 91nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

TargetProtein ENL(Human)
Bridge Medicines

US Patent
LigandPNGBDBM737259(US20250136592, Example 92)
Affinity DataIC50: 93nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: